Gain Therapeutics, Inc. (NASDAQ:GANX) Cap table
Cap table
Built by 6ix from Gain Therapeutics, Inc.’s releases · as of Oct 30, 2026
- Common shares
- 44,525,347
- Fully diluted
- 44,525,347
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 44,525,347 | Oct 30, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 30, 2026 | 44,525,347 |
| Sep 30, 2026 | 44,324,134 |